Tushar Tomar

PamGene (Netherlands) — Netherlands

Medicine · Health Sciences

17h-index1.1kcitations89works5.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ovarian cancer diagnosis and treatment(34), Cytokine Signaling Pathways and Interactions(17), Chromatin Remodeling and Cancer(12), Renal cell carcinoma treatment(10), Neurofibromatosis and Schwannoma Cases(8)

Publications89 total

Integrative Kinase Activity Profiling and Phosphoproteomics of rd10 Mouse Retina during cGMP-Dependent Retinal Degeneration
International Journal of Molecular Sciences·2024· 5 citedOpen Access
The PKG Inhibitor CN238 Affords Functional Protection of Photoreceptors and Ganglion Cells against Retinal Degeneration
International Journal of Molecular Sciences·2023· 11 citedOpen Access
Supplementary Figure 1 from Selective Targeting of Interferon γ to Stromal Fibroblasts and Pericytes as a Novel Therapeutic Approach to Inhibit Angiogenesis and Tumor Growth
2023Open Access
Supplementary Figure 3 from Selective Targeting of Interferon γ to Stromal Fibroblasts and Pericytes as a Novel Therapeutic Approach to Inhibit Angiogenesis and Tumor Growth
2023Open Access
Supplementary Table 1 from Selective Targeting of Interferon γ to Stromal Fibroblasts and Pericytes as a Novel Therapeutic Approach to Inhibit Angiogenesis and Tumor Growth
2023Open Access
Supplementary Figure 3 from Selective Targeting of Interferon γ to Stromal Fibroblasts and Pericytes as a Novel Therapeutic Approach to Inhibit Angiogenesis and Tumor Growth
2023Open Access
Supplementary Figure Legend from Selective Targeting of Interferon γ to Stromal Fibroblasts and Pericytes as a Novel Therapeutic Approach to Inhibit Angiogenesis and Tumor Growth
2023Open Access
Supplementary Figure Legend from Selective Targeting of Interferon γ to Stromal Fibroblasts and Pericytes as a Novel Therapeutic Approach to Inhibit Angiogenesis and Tumor Growth
2023Open Access
Supplementary Figure 4 from Selective Targeting of Interferon γ to Stromal Fibroblasts and Pericytes as a Novel Therapeutic Approach to Inhibit Angiogenesis and Tumor Growth
2023Open Access
Supplementary Table 1 from Selective Targeting of Interferon γ to Stromal Fibroblasts and Pericytes as a Novel Therapeutic Approach to Inhibit Angiogenesis and Tumor Growth
2023Open Access
Supplementary Figure 1 from Selective Targeting of Interferon γ to Stromal Fibroblasts and Pericytes as a Novel Therapeutic Approach to Inhibit Angiogenesis and Tumor Growth
2023Open Access
Supplementary Figure 2 from Selective Targeting of Interferon γ to Stromal Fibroblasts and Pericytes as a Novel Therapeutic Approach to Inhibit Angiogenesis and Tumor Growth
2023Open Access
Supplementary Figure 2 from Selective Targeting of Interferon γ to Stromal Fibroblasts and Pericytes as a Novel Therapeutic Approach to Inhibit Angiogenesis and Tumor Growth
2023Open Access
Data from Selective Targeting of Interferon γ to Stromal Fibroblasts and Pericytes as a Novel Therapeutic Approach to Inhibit Angiogenesis and Tumor Growth
2023Open Access
Data from Selective Targeting of Interferon γ to Stromal Fibroblasts and Pericytes as a Novel Therapeutic Approach to Inhibit Angiogenesis and Tumor Growth
2023Open Access
Supplementary Methods from Selective Targeting of Interferon γ to Stromal Fibroblasts and Pericytes as a Novel Therapeutic Approach to Inhibit Angiogenesis and Tumor Growth
2023Open Access
Supplementary Methods from Selective Targeting of Interferon γ to Stromal Fibroblasts and Pericytes as a Novel Therapeutic Approach to Inhibit Angiogenesis and Tumor Growth
2023Open Access
Supplementary Figure 4 from Selective Targeting of Interferon γ to Stromal Fibroblasts and Pericytes as a Novel Therapeutic Approach to Inhibit Angiogenesis and Tumor Growth
2023Open Access
Figure S4 from Integrative Kinome Profiling Identifies mTORC1/2 Inhibition as Treatment Strategy in Ovarian Clear Cell Carcinoma
2023Open Access
Table S3 from Integrative Kinome Profiling Identifies mTORC1/2 Inhibition as Treatment Strategy in Ovarian Clear Cell Carcinoma
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Steven de Jong(23), Gert Jan Meersma(21), G. Bea A. Wisman(21), Harry Klip(19), Evelien W. Duiker(17), Joseph J. Caumanns(15), Katrien Berns(15), Rudolf S.N. Fehrmann(15), Els Van Nieuwenhuysen(15), René Bernards(15), E. Marielle Hijmans(14), Annemiek M.C. Gennissen(14), Desirée Weening(14), Hiroaki Itamochi(14), Anna K.L. Reyners(14), Michael J. Birrer(14), Helga B. Salvesen(14), Ignace Vergote(14), James D. Brenton(14), Elena Ioana Braicu(14)